At the IGTP TODAY
For the first time the IGTP has participated in the European Researchers' Night, part of the European Commission's Horizon 2020 Programme, which aims bring scientists and society together. Five researchers from the institute have participated in science popularization events.
In an in vitro study researchers have shown how the nanoparticles are more effective than antibiotics alone. In the future, the nanoparticles will be administered orally as a non-invasive treatment that is much more acceptable to patients.
The project, called "Innovation in Tuberculosis - INNOVA4TB", is promoted and coordinated by the research group Innovation in Respiratory Infections and Tuberculosis Diagnosis, led by Dr Jose Domínguez and Dr Cristina Prat. The proposal has received more than a million euros in funding from the 2018 call for Marie Skłodowska-Curie (MSCA) actions
The Innovation in Respiratory Infections and Tuberculosis Diagnosis Group at the IGTP is partnering with Mind the Byte to work on the characterization and binding analysis of an immunostimulant known to trigger T-cell activation, which is crucial for the initiation and regulation of the immune response.
The IGTP research group for Innovation in respiratory infections and tuberculosis diagnosis has taken part in the 2017 edition of IDEA2 Global, a mentoring programme of MIT (Massachusetts Institute of Technology) to encourage innovative ideas in health and help to convert them into transferable projects from the point of view both of applications in health and of business.
Aquest dimecres 15 de novembre més de 200 alumnes de centres de Badalona han visitat les institucions del Campus Can Ruti en el marc de la Setmana de la Ciència. L’IGTP és un dels impulsors d’aquesta jornada de portes obertes en el marc de la Setmana de la Ciència, a Badalona.
